首页> 外文期刊>Clinical Pharmacology and Therapeutics >Drug-induced liver injury: Hy's rule revisited.
【24h】

Drug-induced liver injury: Hy's rule revisited.

机译:药物性肝损伤:再次探讨Hy规则。

获取原文
获取原文并翻译 | 示例
           

摘要

Drag-induced liver injury is a potential complication of many drags. This is to be expected because the liver plays a central role in drag metabolism. Only a very few drags causing drag-induced liver injury have a predictable, dose-dependent toxic mechanism of action, the most widely recognized being acetaminophen (INN, paracetamol) and, to some extent, methotrexate. When acetaminophen overdose is excluded, in most cases drag-induced liver injuries are due to rare, unpredictable reactions of commonly used drags. These unpredictable reactions are mostly either idiosyncratic or immune-mediated, or both, but may also, in some cases, have a dose-related component. Current definition of drag-induced liver injury is dependent on nonspecific elevations in liver test results, in particular, increases in aminotransferase levels.
机译:药物引起的肝损伤是许多药物的潜在并发症。这是可以预期的,因为肝脏在药物代谢中起着核心作用。仅有极少数引起药物引起的肝损伤的药物具有可预测的,剂量依赖性的毒性作用机制,最广为人知的是对乙酰氨基酚(INN,扑热息痛),在某种程度上为甲氨蝶呤。当排除对乙酰氨基酚过量时,在大多数情况下,药物引起的肝损伤是由于常用药物罕见,不可预测的反应引起的。这些不可预测的反应大多是特异反应或免疫介导的,或两者兼有,但在某些情况下,也可能具有剂量相关的成分。药物诱导的肝损伤的当前定义取决于肝试验结果的非特异性升高,尤其是转氨酶水平的升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号